Robert Hayes joins the cell therapy startup as it works to move a treatment for mucopolysaccharidosis type I into clinical testing.
The agency was less likely to go against a recommendation when the panellists were united in their opinion.
Scientists at Boston Children's Hospital have created a gene therapy technique that suppressed heart arrhythmias in mice.
Orum Therapeutics raised $30 million to expand the applications for its cell-penetrating antibody technology.
Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.
The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.
After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.
Trefoil Therapeutics raised $28 million to push its regenerative treatment for corneal dystrophies toward the clinic.
Notable Labs is adding $40 million to its reserves as it scales up its capabilities with plans to take its platform worldwide.
The financing sets AM-Pharma up to advance in sepsis-associated acute kidney injury independently now Pfizer has turned down its option to buy.
